Results 181 to 190 of about 1,265,387 (249)

Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients. [PDF]

Transl Oncol
Tian H, Wang R, Cong D, Bai Y, Zhang W.
europepmc   +1 more source

Pola entuzjazmu

, 2002
openaire   +1 more source

Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Caused by Pola-R-CHOP: A Case Report. [PDF]

Cureus
Aamir M, Nur AM.
europepmc   +1 more source

Poland takes a lead in effective lipid disorders management healthcare programmes in Europe. [PDF]

Am J Prev Cardiol
Banach M, Mastalerz-Migas A, Wita K, Myśliwiec M.   +3 more
europepmc   +1 more source

Low serum albumin levels and the nongerminal center B-cell subtype according to the Hans algorithm as strong prognostic factors in ≥ 80-year-old patients with large B-cell lymphoma treated with rituximab-containing chemotherapy. [PDF]

Ann Hematol
Kawashima I, Nakadate A, Hyuga H, Matsuura M, Sakamoto Y, Suzuki J, Kumagai T, Suzuki M, Yamanda-Koshiishi M, Yamamoto T, Nakajima K, Oishi N, Kondo T, Kirito K.   +13 more
europepmc   +1 more source

Pola-R-CHP performed well in first-line Polarix trial-ineligible and IPI 0-1 DLBCL patients : Article type: research. [PDF]

Ann Hematol
Ren Y, Cheng L, Zhuang J, Wang Z, Yuan L, Cheng Z, Ke Y, Wang W, Li J, Liu P.   +9 more
europepmc   +1 more source

Clinical Impact of the Geriatric Nutritional Risk Index on Chemotherapy-Related Adverse Events in Diffuse Large B-Cell Lymphoma: A Multicenter Study. [PDF]

Nutrients
Fujita K, Tsukasaki H, Lee S, Morishita T, Negoro E, Oiwa K, Hara T, Tsurumi H, Ueda T, Yamauchi T.   +9 more
europepmc   +1 more source

Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial. [PDF]

J Clin Oncol
Hutchings M, Sureda A, Bosch F, Larsen TS, Corradini P, Avigdor A, Terol MJ, Dominguez AR, Pinto A, Skarbnik A, Cordoba R, Jørgensen JM, Zinzani PL, Leung W, Bottos A, Li D, Relf J, Tandon M, Sellam G, Gritti G.   +19 more
europepmc   +1 more source